The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

That, he said, is worrying. “My biggest concern is that we have drugs that are demonstrating as effective for acute pain that all of a sudden extrapolate the data to chronic pain,” he said.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment ...